|
Real-time Estimate
Cboe Europe
17:17:03 12/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 134.33 CHF | +1.20% |
|
+0.31% | +22.76% |
| 11-11 | Novartis AG : Jefferies gives a Neutral rating | ZD |
| 11-11 | Amgen's Sjogren's drug cuts disease activity in trial | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1.20% | +0.31% | +12.15% | +8.33% | +22.76% | +28.50% | +58.99% | +76.52% | +86.47% | 301B | |
| +0.35% | +1.36% | +21.88% | +18.29% | +33.74% | +45.38% | +140.47% | +447.27% | +1,750.51% | 1,280B | |
| -0.13% | +1.48% | +7.26% | +7.93% | +35.50% | +44.67% | +90.43% | +71.97% | +136.69% | 675B | |
| +0.37% | +0.05% | +6.70% | +17.95% | +29.10% | +31.00% | +112.84% | +152.92% | +367.48% | 521B | |
| +0.78% | +3.60% | +12.72% | +11.03% | +23.64% | +39.74% | +69.97% | +9.97% | +73.79% | 386B | |
| -0.59% | -2.11% | +1.09% | +12.85% | +39.83% | +61.83% | +45.16% | +75.17% | +130.15% | 363B | |
| +0.79% | +0.01% | +16.78% | +20.01% | +1.84% | +3.89% | +37.04% | +59.57% | +221.70% | 286B | |
| +0.62% | -2.17% | +12.83% | +12.99% | +43.02% | +38.31% | +75.12% | +121.27% | +214.08% | 253B | |
| -0.67% | -2.72% | +12.28% | +25.01% | +38.28% | +38.49% | +123.56% | +151.71% | +122.10% | 211B | |
| +1.89% | +2.56% | +8.50% | -7.11% | -14.47% | -13.35% | -59.88% | -24.12% | +143.29% | 178B | |
| +0.31% | -4.35% | +4.14% | +10.63% | +18.27% | +15.44% | -0.10% | -41.31% | -9.63% | 168B | |
| -0.16% | -0.37% | +7.24% | +3.28% | +20.66% | +27.45% | +46.40% | +194.31% | +494.60% | 139B | |
| +0.18% | -1.99% | +6.41% | -1.10% | +16.63% | +29.13% | +24.30% | +6.28% | +11.60% | 129B | |
| -0.26% | +0.97% | +15.01% | +19.74% | +31.64% | +26.08% | +130.09% | +384.51% | +654.94% | 125B | |
| +1.62% | +4.07% | +22.86% | +16.64% | +6.35% | -2.40% | +3.14% | -1.40% | +13.98% | 115B | |
| +1.56% | +0.98% | +7.76% | +2.11% | +4.60% | +4.66% | +35.62% | -4.18% | -0.70% | 100B | |
| -0.85% | -3.75% | +10.53% | +310.58% | +743.30% | +841.65% | +255.02% | +10.13% | - | 101B | |
| +4.73% | +3.09% | +28.51% | +20.38% | +24.30% | +42.23% | +20.09% | +53.10% | +128.55% | 96.27B | |
| +0.03% | -0.58% | +15.85% | -0.50% | -13.28% | -8.94% | +51.44% | +73.58% | +550.80% | 73.55B | |
| +1.76% | +2.76% | +11.43% | +10.36% | +26.02% | +33.54% | +2.52% | -27.80% | +62.73% | 73.13B | |
| Average | +0.88% | -0.30% | +12.10% | +25.97% | +56.59% | +66.36% | +63.11% | +89.47% | +271.22% | 279B | |
| Weighted average by Cap. | +1.01% | +0.02% | +12.76% | +18.51% | +39.64% | +48.70% | +83.80% | +162.94% | +549.00% |
- Stock Market
- Stocks
- NOVN Stock
- Sector Novartis AG
Select your edition
All financial news and data tailored to specific country editions
